Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stockley

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 6, 2010
Prevalence of Connexin 26 (GJB2) and Pendred (SLC26A4) mutations in a population of adult cochlear implant candidatesJordan B Hochman, Tracy L Stockley, D Shipp, et al.
Endocrine Pathology|April 13, 2016
Establishment and Characterization of a Human Neuroendocrine Tumor XenograftZhaoying Yang, Le Zhang, Stefano Serra, et al.
Trends in Biotechnology|March 24, 1999
The in vivo delivery of heterologous proteins by microencapsulated recombinant cellsP L Chang, J M Van Raamsdonk, G Hortelano, et al.
American Journal of Medical Genetics|January 25, 2002
Parents of children with spinal muscular atrophy are not obligate carriers: carrier testing is important for reproductive decision-makingSusan Zeesman, Donald T Whelan, Nancy Carson, et al.
Hereditary Cancer in Clinical Practice|April 14, 2022
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?Jeanna M McCuaig, Sarah E Ferguson, Danielle Vicus, et al.
Molecular Oncology|October 8, 2020
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing programMelanie Care, Jeanna McCuaig, Blaise Clarke, et al.
Cancer Cytopathology|June 22, 2021
Validation of BRCA testing on cytologic samples of high-grade serous carcinomaSi Kei Lou, Sylvie Grenier, Melanie Care, et al.
Journal of Genetic Counseling|December 8, 2022
Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancerJeanna M McCuaig, Tracy L Stockley, Sarah E Ferguson, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in OntarioAnne Tierens, Tracy L Stockley, Clinton Campbell, et al.
Journal of Medical Economics|July 19, 2022
Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systemsDon Husereau, Terrence Sullivan, Harriet E Feilotter, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 6, 2010
Prevalence of Connexin 26 (GJB2) and Pendred (SLC26A4) mutations in a population of adult cochlear implant candidatesJordan B Hochman, Tracy L Stockley, D Shipp, et al.
Endocrine Pathology|April 13, 2016
Establishment and Characterization of a Human Neuroendocrine Tumor XenograftZhaoying Yang, Le Zhang, Stefano Serra, et al.
Trends in Biotechnology|March 24, 1999
The in vivo delivery of heterologous proteins by microencapsulated recombinant cellsP L Chang, J M Van Raamsdonk, G Hortelano, et al.
American Journal of Medical Genetics|January 25, 2002
Parents of children with spinal muscular atrophy are not obligate carriers: carrier testing is important for reproductive decision-makingSusan Zeesman, Donald T Whelan, Nancy Carson, et al.
Hereditary Cancer in Clinical Practice|April 14, 2022
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?Jeanna M McCuaig, Sarah E Ferguson, Danielle Vicus, et al.
Molecular Oncology|October 8, 2020
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing programMelanie Care, Jeanna McCuaig, Blaise Clarke, et al.
Cancer Cytopathology|June 22, 2021
Validation of BRCA testing on cytologic samples of high-grade serous carcinomaSi Kei Lou, Sylvie Grenier, Melanie Care, et al.
Journal of Genetic Counseling|December 8, 2022
Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancerJeanna M McCuaig, Tracy L Stockley, Sarah E Ferguson, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in OntarioAnne Tierens, Tracy L Stockley, Clinton Campbell, et al.
Journal of Medical Economics|July 19, 2022
Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systemsDon Husereau, Terrence Sullivan, Harriet E Feilotter, et al.
Pageof 12